BR9812857A - Compostos úteis como agentes neuro-protetores - Google Patents

Compostos úteis como agentes neuro-protetores

Info

Publication number
BR9812857A
BR9812857A BR9812857-4A BR9812857A BR9812857A BR 9812857 A BR9812857 A BR 9812857A BR 9812857 A BR9812857 A BR 9812857A BR 9812857 A BR9812857 A BR 9812857A
Authority
BR
Brazil
Prior art keywords
neuroprotective agents
compounds useful
useful
neuroprotective
agents
Prior art date
Application number
BR9812857-4A
Other languages
English (en)
Inventor
Benjamin Alan Anderson
Lawrence Joseph Heinz
Jill Ann Panetta
Michael Leroy Phillips
John Allan Rieck Iii
John Robert Rizzo
John Kevin Shadle
David Lee Varie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9812857A publication Critical patent/BR9812857A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"COMPOSTOS úTEIS COMO AGENTES NEUROPROTETORES "<D>. Esta invenção refere-se a novos fenil oxazóis, tiazóis, oxazolinas, oxadiazóis e benzoxazóis úteis como agentes neuroprotetores.
BR9812857-4A 1997-10-06 1998-09-23 Compostos úteis como agentes neuro-protetores BR9812857A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6101397P 1997-10-06 1997-10-06
PCT/US1998/019854 WO1999018091A1 (en) 1997-10-06 1998-09-23 Novel compounds useful as neuro-protective agents

Publications (1)

Publication Number Publication Date
BR9812857A true BR9812857A (pt) 2000-08-08

Family

ID=22033099

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812857-4A BR9812857A (pt) 1997-10-06 1998-09-23 Compostos úteis como agentes neuro-protetores

Country Status (16)

Country Link
US (1) US6448396B2 (pt)
EP (1) EP0908454A3 (pt)
JP (1) JP2001519341A (pt)
KR (1) KR20010024402A (pt)
CN (1) CN1281442A (pt)
AU (1) AU9575698A (pt)
BR (1) BR9812857A (pt)
CA (1) CA2305538A1 (pt)
EA (1) EA200000403A1 (pt)
HU (1) HUP0004862A3 (pt)
ID (1) ID24564A (pt)
IL (1) IL135433A0 (pt)
NO (1) NO20001751L (pt)
PL (1) PL339673A1 (pt)
TR (2) TR200100352T2 (pt)
WO (1) WO1999018091A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT971709E (pt) 1996-10-07 2003-09-30 Lilly Co Eli Novos compostos uteis como agentes neuro-protectores
US6472387B1 (en) 1996-10-07 2002-10-29 Eli Lilly And Company Methods of using compounds as neuro-protective agents
TWI292316B (en) * 1999-10-11 2008-01-11 Sod Conseils Rech Applic Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
TWI248438B (en) * 2001-04-10 2006-02-01 Sod Conseils Rech Applic Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
AU2003267980A1 (en) 2002-07-03 2004-01-23 Janssen Pharmaceutica, N.V. Substituted heteroaryl and heterocyclic compounds useful in treating inflammatory disorders
KR101799429B1 (ko) * 2010-05-03 2017-11-21 에스케이바이오팜 주식회사 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물
ES2532706T3 (es) * 2010-10-14 2015-03-31 Daiichi Sankyo Company, Limited Derivados de acilbenceno

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636516A (en) 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
DE3425118A1 (de) 1984-07-07 1986-01-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue redox-indikatoren
DE3621775A1 (de) 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
CA2009470A1 (en) 1989-02-08 1990-08-08 Yu Momose Oxazole compounds and their use
SG86971A1 (en) 1990-11-30 2002-03-19 Teijin Ltd 2-arylthiazole derivatives and pharmaceutical composition thereof
US5633271A (en) 1992-05-26 1997-05-27 E. I. Du Pont De Nemours And Company Arthropodicidal oxazolines and thiazolines
DE4304197A1 (de) * 1993-02-12 1994-08-18 Bayer Ag Substituierte Oxazole
US5428048A (en) 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
PT971709E (pt) * 1996-10-07 2003-09-30 Lilly Co Eli Novos compostos uteis como agentes neuro-protectores

Also Published As

Publication number Publication date
WO1999018091A1 (en) 1999-04-15
EA200000403A1 (ru) 2000-10-30
AU9575698A (en) 1999-04-27
TR200001750T2 (tr) 2001-01-22
CA2305538A1 (en) 1999-04-15
US20010027194A1 (en) 2001-10-04
EP0908454A2 (en) 1999-04-14
EP0908454A3 (en) 2001-07-25
CN1281442A (zh) 2001-01-24
JP2001519341A (ja) 2001-10-23
HUP0004862A3 (en) 2001-12-28
US6448396B2 (en) 2002-09-10
ID24564A (id) 2000-07-27
KR20010024402A (ko) 2001-03-26
NO20001751D0 (no) 2000-04-05
IL135433A0 (en) 2001-05-20
TR200100352T2 (tr) 2001-06-21
NO20001751L (no) 2000-05-03
PL339673A1 (en) 2001-01-02
HUP0004862A2 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
DK0971709T3 (da) Hidtil ukendte forbindelser nyttige som neurobeskyttende midler
NO995846L (no) Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet
BR0013493B1 (pt) derivado de oxazol, composição farmacêutica, composto, e, uso de um derivado de oxazol ou um sal do mesmo
BR0111520A (pt) Tiazina oxazolidinona usada como agente antimicrobiano
FI970328A0 (fi) Heterosykliset yhdisteet, jotka ovat käyttökelpoisia allosteerisinä effektoreina muskariinireseptoreissa
DE60314124D1 (de) 2-(2,6-dichlorphenyl)-diarylimidazole
EP1066279A4 (en) ANOREECTIC IMIDAZOLONE COMPOUNDS: II. phenyl derivatives
NO20062629L (no) Oksazolderivater av tetrackliner
DE69813386D1 (de) Rucksackarbeitsmaschine
HUP0003039A2 (hu) Szinergetikus fungicid hatóanyagkeverék és alkalmazása
BR9812857A (pt) Compostos úteis como agentes neuro-protetores
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht &lt;if&gt;
ATE246189T1 (de) Bizyklische oxazolidinone als antibakterielle mittel
TR200101119T2 (tr) Beyaz sineğe karşı aktiviteye sahip 3-(sübstitüe fenil)-5-tienil-1,2,4-triazol bileşikleri
MA25264A1 (fr) 3-[benz(ox/thi)azol-7-yl)-1h-pyrimidine-2,4-diones
DK1240163T3 (da) 3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler
DE69937603D1 (de) Dihydro-benzo(1,4)oxazine und tetrahydro-quinoxaline
ES2195405T3 (es) Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion.
DE50001813D1 (de) Substituierte benzoxazole
DK0840735T3 (da) Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl]
ATE252573T1 (de) 2-aryloxy-4-methyl-6-pyrazol-1-yl-pyridine wirksam als herbizide
FR2785212B1 (fr) Machine portative d&#39;usinage perfectionnee
DE50008543D1 (de) Herbizide halogenalkyl-substituierte 3-(4,5-dihydroisoxazol-3-yl)-benzoyl-cyclohexenone
IT246756Y1 (it) Accessorio per apparecchi per l&#39;igiene dentale
FR2812581B1 (fr) Machine de moulage par injection, et utilisation d&#39;une telle machine

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1890 DE 27/03/2007.